Opthea Ltd (CKDXF)
Ceryvyn Therapeutics Ltd is a clinical-stage biopharmaceutical company developing therapies for the rare lung disease lymphangioleiomyomatosis (LAM). Its lead program, CYV-101, is a fusion protein designed to neutralize VEGF-C and VEGF-D, key signaling proteins involved in the disease. The company was formerly known as Opthea Limited.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Ceryvyn Therapeutics Ltd
OTC:CKDXFHealthcare · Biotechnology
Mkt Cap-
Float1.17B
O/S-
Inst Own-
SI0.3%
Dilution
Delisting Issues Timeline
Financials Summary
Debt & Equity
Total Debt
Total Equity
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in CKDXF's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Accounts Receivable
Accounts Payable
Inventory
PP&E (Net)
Goodwill
Intangible Assets
Income Statement
Balance Sheet
Cash Flow Statement